To determine the status of STIL expression in NSCLC, we examined STIL mRNA expression levels in primary LUAD (59 non-tumorous and 515 tumor samples) and primary LUSC (51 non-tumorous and 501 tumor samples) using the TCGA dataset. This evidence concerns the gene STIL and neoplasm.